Need Information?
1-866-STLUKES
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Learn more.
A Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Subjects With Previously Untreated Multiple Myeloma
A Phase 2, Randomized Study of Bortezomib/Dexamethasone With or Without Elotuzumab in Subjects With Relapsed/Refractory Multiple Myeloma
Grand Slam Baseball Combine: Opportunity for High School Players
St. Luke's Blue Ribbon 5K Race and Family Fun Walk
Dr. Israel Zighelboim Participates in Women's Cancer Research Trial that Gains National Recognition
More >>